Results 61 to 70 of about 529,151 (288)

The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response Criteria

open access: yesArthritis &Rheumatology, EarlyView.
Disease classification criteria and response criteria are important tools in the conduct of observational studies and clinical trials for rheumatic diseases. This paper updates methodologic guidance for classification and response criteria funded, developed and/or endorsed by the American College of Rheumatology (ACR), incorporating contemporary ...
Sindhu R. Johnson   +4 more
wiley   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo   +7 more
wiley   +1 more source

Antinuclear antibodies in children with Wilson’s disease

open access: yesАллергология и Иммунология в Педиатрии
.
O. V. Kurbatova   +16 more
doaj   +1 more source

Antinuclear human autoantibodies as markers in Nicotiana tabacum pollen tubes

open access: yesActa Societatis Botanicorum Poloniae, 2014
In the present paper we report on the use of antinuclear human autoantibodies as specific markers in Nicotiana tabacum pollen tubes. The antibodies have been tested by fluorescence techniques using a confocal laser scanning microscope. All the antibodies
C. Poggialini   +5 more
doaj   +1 more source

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

open access: yesArthritis &Rheumatology, EarlyView.
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz   +13 more
wiley   +1 more source

ANTINUCLEAR ANTIBODIES IN DRUG-FREE SCHIZOPHRENICS

open access: yesEurasian Journal of Medicine, 2019
The nature of the association between auto-immune phenomena and schizophrenia is not entirely clear. In an attempt to define the auto-immune status of patients with schizophrenia, sera of patients and healthy controls were tested for antinuclear ...
Nazan Aydın   +3 more
doaj  

Cirrosis biliar primaria: patología subdiagnosticada. Reporte de caso

open access: yesRevista Médica Hondureña
Introduction: Primary biliary cirrhosis is a chronic, cholestatic, autoimmune, and progressive liver disease that pre-dominantly affects women.
Delmy Saraí Castillo Álvarez   +2 more
doaj   +1 more source

Antinuclear antibodies in postinfectious smell loss - a pilot study [PDF]

open access: yesRhinology Online, 2019
Background: Numerous diseases are mediated by autoimmune mechanisms some of which have been shown to be associated with reduced olfactory function, e.g. systemic lupus erythematosus, Sjögren syndrome, psoriasis vulgaris.
U. Walliczek-Dworschak   +3 more
doaj   +1 more source

Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Primary Sjögren's disease (SjD) is a systemic autoimmune disease associated with an increased risk of lymphoma. The molecular mechanisms underlying lymphomagenesis remain poorly understood, and sensitive biomarkers for early identification of patients at high risk of developing lymphoma are lacking.
Hanna Lidberg   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy